Table 2:
Multivariate Analysis of NCCN Treatment Non-adherence for All Stages
| Characteristic | OR | 95% Confidence Interval | ||
|---|---|---|---|---|
| Age | 1.02 | 1.02 | - | 1.02 |
| Size Category | ||||
| <50mm | 1.00 | Referent | ||
| 50–99mm | 0.93 | 0.85 | - | 1.02 |
| 100+mm | 0.91 | 0.83 | - | 0.99 |
| Size Unknown | 1.12 | 1.03 | - | 1.22 |
| Grade | ||||
| Grade I | 1.00 | Referent | ||
| Grade II | 1.00 | 0.89 | - | 1.13 |
| Grade III | 0.85 | 0.76 | - | 0.95 |
| Grade IV | 0.73 | 0.65 | - | 0.83 |
| Grade Unknown | 2.25 | 2.00 | - | 2.54 |
| Stage | ||||
| Stage 1 | 1.00 | Referent | ||
| Stage 2 | 0.75 | 0.68 | - | 0.84 |
| Stage 3 | 0.25 | 0.23 | - | 0.27 |
| Stage 4 | 0.33 | 0.30 | - | 0.36 |
| Histology | ||||
| Serous | 1.00 | Referent | ||
| Mucinous | 1.40 | 1.24 | - | 1.58 |
| Endometrioid | 1.22 | 1.11 | - | 1.34 |
| Clear cell | 0.91 | 0.81 | - | 1.03 |
| Adenocarcinoma, NOS | 2.89 | 2.59 | - | 3.22 |
| Others | 1.78 | 1.66 | - | 1.91 |
| Race/Ethnicity | ||||
| Non-Hispanic White | 1.00 | Referent | ||
| Non-Hispanic Black | 1.21 | 1.06 | - | 1.39 |
| Hispanic | 1.01 | 0.93 | - | 1.09 |
| Asian/Pacific Islander | 1.02 | 0.93 | - | 1.11 |
| American Indian/Other | 1.47 | 1.05 | - | 2.05 |
| Socioeconomic Status | ||||
| Lowest SES | 1.28 | 1.16 | - | 1.42 |
| Lower-middle SES | 1.15 | 1.06 | - | 1.26 |
| Middle SES | 1.09 | 1.01 | - | 1.19 |
| Higher-middle SES | 1.06 | 0.98 | - | 1.14 |
| Highest SES | 1.00 | Referent | ||
| Insurance | ||||
| Managed Care | 1.00 | Referent | ||
| Medicare | 1.10 | 1.03 | - | 1.19 |
| Medicaid | 1.04 | 0.94 | - | 1.15 |
| Other Insurance | 1.01 | 0.93 | - | 1.10 |
| Not insured | 1.34 | 1.14 | - | 1.58 |
| Unknown | 0.99 | 0.82 | - | 1.20 |
| Marital Status | ||||
| Not Married | 1.00 | Referent | ||
| Married | 0.85 | 0.81 | - | 0.90 |
| Charlson Comorbidity Score | ||||
| CCS 0 | 1.00 | Referent | ||
| CCS 1 | 0.99 | 0.92 | - | 1.05 |
| CCS 2+ | 1.19 | 1.10 | - | 1.28 |
| CCS Unknown | 1.26 | 1.13 | - | 1.41 |
| Year of Diagnosis | 1.01 | 1.00 | - | 1.01 |
| Hospital Quality Measure | ||||
| Low | 2.57 | 2.35 | - | 2.81 |
| Intermediate | 1.76 | 1.64 | - | 1.89 |
| High | 1.00 | Referent | ||
| Distance Traveled to Care | ||||
| <6 km | 1.00 | Referent | ||
| 6–9 km | 0.92 | 0.85 | - | 1.00 |
| 10–16 km | 0.89 | 0.82 | - | 0.97 |
| 17–32 km | 0.91 | 0.84 | - | 1.00 |
| >32 km | 0.76 | 0.70 | - | 0.84 |
| Closest High Quality Hospital | ||||
| <9 km | 1.00 | Referent | ||
| 9–14 km | 1.06 | 0.97 | - | 1.15 |
| 15–24 km | 1.05 | 0.97 | - | 1.15 |
| 25–48 km | 1.13 | 1.04 | - | 1.23 |
| >48 km | 1.18 | 1.07 | - | 1.29 |
CCS, Charlson Comorbidity Score; km, kilometers; NCCN, National Comprehensive Cancer Network; NOS, Not otherwise specified; OR, Odds Ratio